Tag: 14D9— 3 items —
Major merger money for Pharmasset execs…
December 7, 2011—Yesterday, clinical-stage pharmaceutical company Pharmasset, Inc. (VRUS) filed regulatory documents related to the proposed acquisition by Gilead Sciences, Inc. (GILD), a deal valued at approximately $11 billion. If shareholders approve the acquisition, they’re slated to get $137 per share – a rather tidy premium of 89%, over the $72.67 that the stock closed at on […]
The Dollar Thrifty opera, Act II…
June 7, 2011—Last August, we wrote this post about Dollar Thrifty Automotive Group, Inc.’s (DTG) dramatic merger negotiations with rivals Avis Budget Group, Inc. (CAR) and Hertz Global Holdings, Inc. (HTZ). At the time, Dollar Thrifty had just announced its intentions to choose a suitor (Hertz) in a proposed $1.3 billion deal that didn’t actually conclude with […]
Who Wants to be a Merger Millionaire?
November 3, 2010—In today’s episode of “Who Wants to Be a Merger Millionaire?,” we tune in to Hawk Corporation (HWK), a company that supplies friction products for the transmissions, clutches, and brakes used in vehicles, airplanes, and farm, mining, and construction equipment. Carlisle Companies, Inc. (CSL) is buying Hawk in a $413 million cash deal that gives […]